Core Scientific (CORZ) Competitors $13.55 -0.24 (-1.74%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$13.58 +0.02 (+0.18%) As of 08/22/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CORZ vs. BCH, WF, CIB, COOP, ALLY, BSAC, CHYM, SSB, UWMC, and GGALShould you be buying Core Scientific stock or one of its competitors? The main competitors of Core Scientific include Banco De Chile (BCH), Woori Bank (WF), BanColombia (CIB), Mr. Cooper Group (COOP), Ally Financial (ALLY), Banco Santander Chile (BSAC), Chime Financial (CHYM), SouthState (SSB), UWM (UWMC), and Grupo Financiero Galicia (GGAL). These companies are all part of the "banking" industry. Core Scientific vs. Its Competitors Banco De Chile Woori Bank BanColombia Mr. Cooper Group Ally Financial Banco Santander Chile Chime Financial SouthState UWM Grupo Financiero Galicia Core Scientific (NASDAQ:CORZ) and Banco De Chile (NYSE:BCH) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk. Do institutionals & insiders hold more shares of CORZ or BCH? 1.2% of Banco De Chile shares are held by institutional investors. 1.4% of Core Scientific shares are held by insiders. Comparatively, 5.9% of Banco De Chile shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate CORZ or BCH? Core Scientific presently has a consensus target price of $18.32, indicating a potential upside of 35.17%. Banco De Chile has a consensus target price of $23.00, indicating a potential downside of 20.55%. Given Core Scientific's stronger consensus rating and higher probable upside, equities analysts clearly believe Core Scientific is more favorable than Banco De Chile.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Core Scientific 1 Sell rating(s) 11 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.45Banco De Chile 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable valuation & earnings, CORZ or BCH? Banco De Chile has higher revenue and earnings than Core Scientific. Core Scientific is trading at a lower price-to-earnings ratio than Banco De Chile, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCore Scientific$510.67M8.10-$171.03M-$0.56-24.20Banco De Chile$4.21B3.47$1.37B$2.8110.30 Which has more volatility & risk, CORZ or BCH? Core Scientific has a beta of 6.6, meaning that its share price is 560% more volatile than the S&P 500. Comparatively, Banco De Chile has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Does the media favor CORZ or BCH? In the previous week, Core Scientific had 15 more articles in the media than Banco De Chile. MarketBeat recorded 18 mentions for Core Scientific and 3 mentions for Banco De Chile. Banco De Chile's average media sentiment score of 1.79 beat Core Scientific's score of 0.95 indicating that Banco De Chile is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Core Scientific 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Banco De Chile 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is CORZ or BCH more profitable? Banco De Chile has a net margin of 32.62% compared to Core Scientific's net margin of 0.00%. Banco De Chile's return on equity of 23.00% beat Core Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Core ScientificN/A N/A N/A Banco De Chile 32.62%23.00%2.51% SummaryBanco De Chile beats Core Scientific on 10 of the 17 factors compared between the two stocks. Get Core Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for CORZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CORZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORZ vs. The Competition Export to ExcelMetricCore ScientificFIN IndustryFinance SectorNASDAQ ExchangeMarket Cap$4.21B$7.55B$12.41B$9.60BDividend YieldN/A4.80%5.52%4.10%P/E Ratio-24.2017.7619.3926.04Price / Sales8.106.6726.09103.40Price / CashN/A24.1621.7558.48Price / BookN/A4.732.356.61Net Income-$171.03M$311.02M$1.01B$265.56M7 Day Performance-4.10%1.24%1.73%1.95%1 Month Performance0.44%-2.23%1.02%-0.37%1 Year Performance25.93%27.67%537.30%19.02% Core Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORZCore Scientific2.4589 of 5 stars$13.55-1.7%$18.32+35.2%+37.1%$4.21B$510.67M-24.20200News CoverageAnalyst ForecastAnalyst RevisionBCHBanco De Chile2.6346 of 5 stars$29.42+0.4%$23.00-21.8%+14.7%$14.86B$3.01T10.4711,614News CoveragePositive NewsAnalyst UpgradeWFWoori Bank3.2159 of 5 stars$53.37-2.6%N/A+46.7%$13.21B$19.04B6.7213,279Positive NewsCIBBanColombia2.4982 of 5 stars$49.59+0.1%$43.75-11.8%+52.4%$11.92B$10.55B7.5234,114News CoveragePositive NewsCOOPMr. Cooper Group3.697 of 5 stars$185.53-3.0%$140.38-24.3%+119.6%$11.87B$2.23B21.237,900Positive NewsOptions VolumeALLYAlly Financial4.6361 of 5 stars$38.46-1.0%$42.80+11.3%-3.1%$11.84B$8.18B24.9710,700News CoveragePositive NewsBSACBanco Santander Chile3.2749 of 5 stars$24.31+0.4%$23.00-5.4%+18.4%$11.45B$4.72B10.138,757News CoverageShort Interest ↓CHYMChime FinancialN/A$30.06+2.3%$38.00+26.4%N/A$10.95BN/A0.001,465SSBSouthState1.9466 of 5 stars$95.95+0.6%N/AN/A$9.71B$2.12B14.304,986UWMCUWM1.9341 of 5 stars$5.37-0.2%$5.54+3.2%-38.1%$8.59B$2.16B-107.409,100Insider TradeGGALGrupo Financiero Galicia3.7078 of 5 stars$49.23+2.0%$67.50+37.1%+36.7%$7.26B$10.79B7.2512,440News CoverageUpcoming EarningsDividend Cut Related Companies and Tools Related Companies Banco De Chile Competitors Woori Bank Competitors BanColombia Competitors Mr. Cooper Group Competitors Ally Financial Competitors Banco Santander Chile Competitors Chime Financial Competitors SouthState Competitors UWM Competitors Grupo Financiero Galicia Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CORZ) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access